Evaluation of the β2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol

Thorax

Volumn 51, Issue 1, 1996, Pages 54-58

  Grove, A ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Formoterol; Intrinsic activity; Salmeterol; 2 agonist antagonist

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL; FORMOTEROL; PLACEBO; PROPRANOLOL; SALMETEROL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DRUG POTENCY; EXERCISE TEST; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERKALEMIA; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0030047064     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.1.54     Document Type: Article

References (18)

1. 2 adrenoceptor agonist bronchodilator. Life Sci 1993;52:2145-60.
2. Waller DG. β-adrenoceptor partial agonists; a renaissance in cardiovascular therapy? Br J Clin Pharmacol 1990;30:157-71.
3. 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone. Thorax 1995;50:134-8.
4. 2 adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro. Br J Pharmacol 1994;113:687-92.
5. O'Donnell SR, Wanstall JC. Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol on β-adrenoceptors on guinea-pig trachea. Eur J Pharmacol 1978;47:333-40.
6. Wilson C, Lincoln C. β-adrenoceptor subtypes in human, rat, guinea-pig, and rabbit atria. J Cardiovasc Pharmacol 1984;6:1216-21.
7. Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW. In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, β-adrenoceptor agonists and theophylline. Br J Clin Pharmacol 1986;22:669-76.
8. Carruthers S, Shanks RG, McDevitt DG. Intrinsic heart rate on exercise and the measurement of β-adrenoceptor blockade. Br J Clin Pharmacol 1976;3:991-9.
9. Lipworth BJ, McDevitt DG. β-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol 1989;36:239-45.
10. Williams ME, Gervino EV, Rossa RM, Landsbergh L, Young JB, Silva P, et al Catecholamine modulation of rapid potassium shifts during exercise. N Engl J Med 1985; 312:823-7.
11. Norgaard A, Botker HE, Klitgaard NA, Toft P. Digitalis enhances exercise-induced hyperkalaemia. Eur J Clin Pharmacol 1991;41:609-11.
12. 2 adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline induced β-adrenoceptor responses in man. Br J Clin Pharmacol 1985;19:619-30.
13. 2 activity of inhaled fenoterol and salbutamol in normal subjects. Thorax 1993;48:656-8.
14. Lipworth BJ, Newnham DM, Clark RA, Dhillon DP, Winter JH, McDevitt DG. Comparison of the relative airways and systemic potencies of fenoterol and salbutamol in asthmatic subjects. Thorax 1995;50:54-61.
15. Lipworth BJ, Brown RA, McDevitt DG. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta-2 adrenoceptor blockade. Br J Clin Pharmacol 1989;28:95-102.
16. Tattersfield AE. Clinical pharmacology of long-acting β-receptor agonists. Life Sci 1993;52:2161-9.
17. Linden A, Bergendal A, Ullman A, Skoogh BE, Lofdahl CG. Salmeterol, formoterol, and salbutamol in the isolated guinea-pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism. Thorax 1993;48:547-53.
18. Advenier C, Zhang Y, Naline E, Grandordy BM. Effects of formoterol on isolated human bronchus. Am Rev Respir Dis 1991;143:A651